Macrophage depletion in stellate ganglia alleviates cardiac sympathetic overactivation and ventricular arrhythmogenesis by attenuating neuroinflammation in heart failure

Basic Res Cardiol. 2021 Apr 21;116(1):28. doi: 10.1007/s00395-021-00871-x.

Abstract

Cardiac sympathetic overactivation is involved in arrhythmogenesis in patients with chronic heart failure (CHF). Inflammatory infiltration in the stellate ganglion (SG) is a critical factor for cardiac sympathoexcitation in patients with ventricular arrhythmias. This study aims to investigate if macrophage depletion in SGs decreases cardiac sympathetic overactivation and ventricular arrhythmogenesis in CHF. Surgical ligation of the coronary artery was used for induction of CHF. Clodronate liposomes were microinjected into bilateral SGs of CHF rats for macrophage depletion. Using cytokine array, immunofluorescence staining, and Western blot analysis, we found that macrophage expansion and expression of TNFα and IL-1β in SGs were markedly increased in CHF rats. Flow cytometry data confirmed that the percentage of macrophages in SGs was higher in CHF rats than that in sham rats. Clodronate liposomes significantly reduced CHF-elevated proinflammatory cytokine levels and macrophage expansion in SGs. Clodronate liposomes also reduced CHF-increased N-type Ca2+ currents and excitability of cardiac sympathetic postganglionic neurons and inhibited CHF-enhanced cardiac sympathetic nerve activity. ECG data from 24-h, continuous telemetry recording in conscious rats demonstrated that clodronate liposomes not only restored CHF-induced heterogeneity of ventricular electrical activities, but also decreased the incidence and duration of ventricular tachycardia/fibrillation in CHF. Macrophage depletion with clodronate liposomes attenuated CHF-induced cardiac sympathetic overactivation and ventricular arrhythmias through reduction of macrophage expansion and neuroinflammation in SGs.

Keywords: Calcium channel; Cardiac sympathetic neuron; Chronic heart failure; Clodronate liposomes; Macrophage depletion; Ventricular arrhythmia.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Calcium Channels, N-Type / metabolism
  • Calcium Signaling
  • Clodronic Acid / pharmacology*
  • Disease Models, Animal
  • Heart / innervation*
  • Heart Failure / complications
  • Heart Failure / drug therapy*
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Heart Rate / drug effects*
  • Inflammation Mediators / metabolism
  • Interleukin-1beta / metabolism
  • Liposomes
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Male
  • Neuroinflammatory Diseases / etiology
  • Neuroinflammatory Diseases / metabolism
  • Neuroinflammatory Diseases / physiopathology
  • Neuroinflammatory Diseases / prevention & control*
  • Rats
  • Rats, Sprague-Dawley
  • Stellate Ganglion / drug effects*
  • Stellate Ganglion / metabolism
  • Stellate Ganglion / physiopathology
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / metabolism
  • Tachycardia, Ventricular / physiopathology
  • Tachycardia, Ventricular / prevention & control*
  • Tumor Necrosis Factor-alpha / metabolism
  • Ventricular Fibrillation / etiology
  • Ventricular Fibrillation / metabolism
  • Ventricular Fibrillation / physiopathology
  • Ventricular Fibrillation / prevention & control*

Substances

  • Anti-Inflammatory Agents
  • Calcium Channels, N-Type
  • IL1B protein, rat
  • Inflammation Mediators
  • Interleukin-1beta
  • Liposomes
  • Tumor Necrosis Factor-alpha
  • Clodronic Acid